BioSpace News Archive

Drug Development

Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitinib in Glioblastoma in China

Epitinib is a potent and highly selective oral EGFR inhibitor that has demonstrated penetration of the blood-brain barrier and encouraging efficacy in clinical studies in other indications.

March 6, 2018
·
6 min read
Business

Glenmark Pharmaceutical S.A. to Invest in New Translational Research Group at Biopôle Lausanne-Epalinges

The new discovery group will enhance current capabilities in translational research

March 6, 2018
·
2 min read
Job Trends

DrFirst Showcases Its 4th Generation Intelligent E-prescribing Mobile App, iPrescribe, with Secure EPCS, PDMP Opioid Visibility and Market-Leading Benefit Check at HIMSS18

DrFirst Showcases its 4th generation Intelligent E-prescribing Mobile App, iPrescribe, with secure EPCS, PDMP opioid visibility and market-leading benefit check at HIMSS18

March 6, 2018
·
4 min read
BioMidwest

UnitedHealthcare Launches Expansion of Direct-to-Consumer Pharmacy Discounts to Millions of Americans

Program to help make prescriptions more affordable at the point of sale and improve the health care experience

March 6, 2018
·
4 min read
Business

DiA Imaging Analysis Collaborates With Google Cloud to Offer Automated Ultrasound Analysis for Transforming Patient Care

New collaboration accelerates global adoption of DiA’s breakthrough automated software tools, enabling quick, accurate and reproducible ultrasound imaging analysis, accessible anywhere and anytime.

March 6, 2018
·
2 min read
OrthoXel Announces World’s First Patient Surgical Implantation of the Apex Tibial Nailing System

Harty successfully completed the world’s first clinical use of the Apex Tibial Nailing System in Cork University Hospital on Saturday 3rd March.

March 6, 2018
·
3 min read
ARANZ Medical announces issuance of new patent and 2017 closing of NZ$3million

ARANZ Medical announced today the issuance of United States Patent 9,861,285, Handheld Skin Measuring or Monitoring Device, the most recent patent to be issued in ARANZ Medical’s growing portfolio of intellectual property.

March 6, 2018
·
2 min read
Pharm Country

Stryker Launches Next Generation Trident® II Acetabular System

System features Trident II Tritanium, building on Trident brand legacy, combining the reproducibility of AMagine™ additive manufactured Tritanium® In-Growth Technology with the precision of Mako Robotic-Arm Assisted Surgery[1]

March 6, 2018
·
5 min read
Deals

SCYNEXIS Announces Pricing of $30.0 Million Public Offering of Common Stock and Warrants

SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten public offering of common stock and warrants.

March 6, 2018
·
4 min read
Study Finds Precision Medicine Initiatives Active in Broader Spectrum of Disease Areas and Datasets, But Not Without Technological Challenges

Oracle Health Sciences today announced the results of a new study that explores the current and planned status of precision medicine initiatives, associated challenges and the future impact of this discipline on life sciences and healthcare communities.

March 6, 2018
·
4 min read